Wednesday June 12, 2024
Keynote: Determining the right model for AI: What now and where next?
As conversations about AI continue to dominate everyday life, what does the rapid advent of this new technology actually mean for the sector? How should boardrooms and investors be investing now? What are the current use cases for productivity, efficiency and clinical support and how do we find the right model to deploy it? This session opens with a keynote outlining what the technology will enable in the not-too-distant future before exploring case studies about how it is already making an impact on quality, outcomes and productivity.
Speakers include:
Dr Dorin Comaniciu, Senior Vice President, Artificial Intelligence & Digital Innovation, Siemens Healthineers
Victor Savevski, Managing Director Innovation and AI, Humanitas Healthcare
Alexander Sukharevsky, Senior Partner and Global Leader of QuantumBlack, McKinsey & Company’s AI arm
Michael Morley, Partner, McKinsey & Company
Ballroom 1+2
Keynote: Determining the right model for AI: What now and where next?
As conversations about AI continue to dominate everyday life, what does the rapid advent of this new technology actually mean for the sector? How should boardrooms and investors be investing now? What are the current use cases for productivity, efficiency and clinical support and how do we find the right model to deploy it? This session opens with a keynote outlining what the technology will enable in the not-too-distant future before exploring case studies about how it is already making an impact on quality, outcomes and productivity.
Speakers include:
Dr Dorin Comaniciu, Senior Vice President, Artificial Intelligence & Digital Innovation, Siemens Healthineers
Victor Savevski, Managing Director Innovation and AI, Humanitas Healthcare
Alexander Sukharevsky, Senior Partner and Global Leader of QuantumBlack, McKinsey & Company’s AI arm
Michael Morley, Partner, McKinsey & Company
Ballroom 1+2
Speakers
Explore more sessions
View the agenda and see how this event will accelerate your business goals.
Explore similar sessions
What is the right model for telemedicine
The unexpected and dramatic fall of telehealth startup Babylon in 2023 highlighted the fragility of the telemedicine model. Despite strong revenue, profitability and therefore sustainability is put into question. So,...
Ballroom 1+2
What is the right model for telemedicine
The unexpected and dramatic fall of telehealth startup Babylon in 2023 highlighted the fragility of the telemedicine model. Despite strong revenue, profitability and therefore sustainability is put into question. So, what is the right business model for telemedicine and what lessons have been learnt from Babylon and other telemedicine provider troubles? This session features three CxOs sharing their models, discussing reimbursement, growth and how to make telemedicine models profitable and sustainable.
Speakers include:
Amon van den Borg, CEO, Arts en Zorg
Dr Sunita Maheshwari, Chief Dreamer and Loop Closer, The Telerad Group
Indian primary care chain- RxDx healthcare- has spent the last decade figuring out the right, scalable and sustainable business model for telemedicine. The group with 8 primary care centres in Bangalore and over 40 nurse-assisted telemedicine centres has developed a hybrid model that keeps out of pocket care including second opinions affordable and suits both patients and doctors.
Dr Kalle Conneryd Lundgren, COO, Kry
Moderated by Guillaume Duparc, Partner, L.E.K. Consulting
Ballroom 1+2
Speakers
Laboratory diagnostics – Growth beyond consolidation
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively?...
Ballroom 3
Laboratory diagnostics – Growth beyond consolidation
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.
Speakers include:
Joe Stringer, Executive Chairman, Automata
Case Study: The future of automation in labs, Automata, and The Royal Marsden
With the demand for genomic testing on the back of screening programs exploding, how are lab groups managing to keep up? Lab automation group, Automata has enabled providers such as a The Royal Marsden NHS Trust to increase genomic test throughput by 3 to 5x whilst simultaneously halving the space required. In this case study Joe explains how this was possible, the future of innovation in laboratories, the impact on the scientific workforce and productivity, and why logistics is now the only significant barrier to scaling innovation.
Jean-Francois Pomerol, CEO & Co-Founder, Tribun Health
Jérôme Thill, Partner, Horasis
Moderated by Dr Stephan Rau, Partner, McDermott, Will & Emery
Ballroom 3
Speakers
Dental Services CxO Summit in partnership with Straumann Group
Dental services continue to see strong investor interest, thanks to strong self-pay and PMI revenue streams. But, as M&A slows, how do dental practices drive organic growth? How are medtech...
Ballroom 2
Dental Services CxO Summit in partnership with Straumann Group
Dental services continue to see strong investor interest, thanks to strong self-pay and PMI revenue streams. But, as M&A slows, how do dental practices drive organic growth? How are medtech and labs becoming more integrated in the value chain? How do you build an oral health patient journey and what is the impact of digitalisation on patient, clinician and management? This summit brings CEOs of dental chains, DSOs and investors together to share insights on innovation, efficiency and value creation through case studies and group discussion.
14:00 Workshop 1: What problem is Enterprise Dentistry able to solve – is a European model replicable for the world?
This session explores strategies and the right model for DSOs to increase access to dentistry and provide a better patient experience. It covers how corporate dental groups can build consumer-centric brands, models that make treatment more affordable and how to get patients to focus and prioritise oral health.
Presentation and lessons learned from:
Kiran Malviya, VP DSO EMEA, Straumann Group
Nilesh Panday, CEO, myDentist
Niklas Virta, Managing Director / CEO, Aqua Dental
14:35 – 14:45 Flashlight: insights of the successful partnership between myDentist and Aqua Dental and Straumann Group
Kiran Malviya, VP DSO EMEA, Straumann Group
14:45 – 15:25 Group work: Tactics to access oral treatments
Lead by Katya Zubareva, Partner, L.E.K. Consulting
15:30 – 16:15 Networking break
16:45 Workshop 2: Catalysts for success with patient conversion – insights and success tactics
Impulse Presentation:
Dr Robert Brody, Chief Clinical Officer, Great Expressions Dental Group
Flashlight presentation: Insights of the successful partnership between Great Expressions Dental Centers and Straumann Group.
Dr Herbert Staehr, SVP Enterprise Consulting, Straumann Group
16:50 – 17:30 Interactive group co-creation: success drivers for building a specialty franchise and ensuring patient conversion
Lead by: Katya Zubareva, Partner, L.E.K. Consulting
17:30 Closing remarks
Ballroom 2